home / stock / psyb:cc / psyb:cc news

PSYB:CC News and Press, Psybio Therapeutics Corp.

Stock Information
Company Name: Psybio Therapeutics Corp.
Stock Symbol: PSYB:CC
Market: TSXVC
Menu
PSYB:CC PSYB:CC Quote PSYB:CC Short PSYB:CC News PSYB:CC Articles PSYB:CC Message Board
Get PSYB:CC Alerts

News, Short Squeeze, Breakout and More Instantly...
PSYB:CC - TSX Venture Exchange Stock Maintenance Bulletins

TSX Venture Exchange Stock Maintenance Bulletins Canada NewsWire VANCOUVER, BC , Dec. 6, 2023 /CNW/ - TSX VENTURE COMPANIES BULLETIN V2023-0173 BULLETIN TYPE:  Cease Trade Order BULLETIN DATE: December 6, 2023 TS...
PSYB:CC - Canadian Investment Regulatory Organization Trading Halt - PSYB

Canadian Investment Regulatory Organization Trading Halt - PSYB Canada NewsWire VANCOUVER, BC , Nov. 27, 2023 /CNW/ - The following issues have been halted by CIRO Company: Psybio Therapeutics Corp. TSX-Venture Symbol: PSYB All Issues: Yes Rea...

PSYB:CC - PsyBio Therapeutics: Top 10 Undervalued Biotechnology Industry Stocks (PSYB)

2023-09-02 20:00:00 ET PsyBio Therapeutics is now ranked among the top 10 undervalued stocks in the Biotechnology industry on the Toronto Stock Exchange or TSX Venture Exchange. A stock is considered undervalued if it trades at a discount to its valuation – a calculation used...

PSYB:CC - PsyBio Therapeutics Awarded Approval to Manufacture Biosynthetic Tryptamines at Scale

PsyBio continues to develop psycho-targeted, biosynthesized tryptamines and with this authorization becomes the first biotechnology company to obtain government sanctioned, formal, written authorization to manufacture biosynthetic tryptamines including PsyBio-11142 at scale Oxford, Ohio and Denv...
PSYB:CC - PsyBio Announces Closing of Third Tranche of Private Placement

Oxford, Ohio and Denver, Colorado--(Newsfile Corp. - April 20, 2023) - PsyBio Therapeutics Corp. (TSXV: PSYB) (OTCQB: PSYBF) (" PsyBio " or the " Company "), an intellectual property driven biotechnology company focused upon discovery and development of novel psycho-targeted therapeutics being de...

PSYB:CC - PsyBio Announces Panel Participation on NextGen Psychedelics at Benzinga Cannabis Capital Conference

Oxford, Ohio and Denver, Colorado--(Newsfile Corp. - April 6, 2023) - PsyBio Therapeutics Corp. (TSXV: PSYB) (OTCQB: PSYBF) (" PsyBio " or the " Company "), an intellectual property driven biotechnology company focused upon discovery and development of novel psycho-targeted therapeutics being des...

PSYB:CC - PsyBio Therapeutics Founder Wins Best Pitch at Investment Summit

Prestigious award recognizes innovative company as a leading player in the emerging field of psychedelic medicine Miami, Florida--(Newsfile Corp. - March 13, 2023) - Evan Levine, CEO and Founder of PsyBio Therapeutics, won Best Pitch at Kahner Global's Cannabis & Psychedelics Investment Summ...
PSYB:CC - PsyBio Announces Closing of Second Tranche of Private Placement

Oxford, Ohio and Denver, Colorado--(Newsfile Corp. - January 13, 2023) - PsyBio Therapeutics Corp. (TSXV: PSYB) (OTCQB: PSYBF) (" PsyBio " or the " Company "), an intellectual property driven biotechnology company focused upon discovery and development of novel psycho-targeted therapeutics being ...

PSYB:CC - PsyBio Announces Appointment of Ian Wisenberg to Board of Directors

Oxford, Ohio and Denver, Colorado--(Newsfile Corp. - January 10, 2023) - PsyBio Therapeutics Corp. (TSXV: PSYB) (OTCQB: PSYBF) (" PsyBio " or the " Company "), an intellectual property driven biotechnology company focused on the discovery and development of novel psycho-targeted therapeutics bein...

PSYB:CC - PsyBio Announces Closing of First Tranche of Private Placement Led by the Chairman and Chief Executive Officer with Participation from the Entire Board of Directors and Management Team and Provides Corporate Update

Oxford, Ohio and Denver, Colorado--(Newsfile Corp. - January 5, 2023) - PsyBio Therapeutics Corp. (TSXV: PSYB) (OTCQB: PSYBF) (" PsyBio " or the " Company "), an intellectual property driven biotechnology company focused upon discovery and development of novel psycho-targeted therapeutics being d...
Next 10